Know before it’s urgent.

40 biomarkers on Essential and 55 on Premium, across lipids, metabolic markers, liver and kidney function, thyroid and the blood count, with minerals and vitamins on Premium, read together rather than as isolated numbers. Every report includes a cardiovascular forecast on the AHA PREVENT equations, ten-year for patients 40 and over and a ten- and thirty-year view from 30 to 39 (under 30, the direction of the biomarkers is tracked instead), a biological-age reading, and a clinical narrative written by the physician.

Standard laboratory reports show numbers beside reference ranges that were not derived from South Asian populations. Here the results are read against South Asian thresholds, as one connected picture, and written up by a physician who has met you. You receive clinical meaning, not data.

In part. It covers the blood and urine side of a full body check-up: 40 biomarkers on Essential across the heart, blood sugar, liver, kidneys, thyroid, blood count and urine, and 55 on Premium, which adds ApoB, hs-CRP, the full liver panel, early kidney damage, vitamins and minerals. The consultation adds a resting ECG and measurements including blood pressure, waist and grip strength. It does not include scans. What it adds is one physician who examines you, reads every result against South Asian thresholds and repeats what can change at three months.

Blood can be drawn at home, office or hotel, or at the centre in Mirihana. The vitals assessment, a resting ECG, the examination and the grip strength measurement take place in person at the centre. Every patient attends one in-person appointment as part of the programme.

A targeted repeat of the biomarkers that can move, placed beside the baseline, with a note on what changed and what to do next. It is included in both programmes at no extra cost. The Month-12 full repeat is not included; it is the Year-2 renewal, purchased separately.

Essential within about a week of the draw; Premium within about 14 days, because the physician waits for every result before writing one complete report. The results consultation is scheduled once the report is complete.

Especially so. The programme is built to find metabolic and cardiovascular risk years before symptoms, which is when a change of direction is easiest and does the most for the years lived in good health.

The cardiovascular forecast uses the AHA PREVENT equations: a ten-year figure from age 40, with the WHO 2019 South-East Asia risk chart shown beside it as a comparison from 40 to 74, and a ten- and thirty-year view from 30 to 39; under 30 the report tracks the direction of the biomarkers instead of a percentage. Phenotypic age on Premium is the published Levine 2018 model, built from nine blood markers; it was derived in US populations and has not been validated in South Asians, so the change between visits matters more than the single value. Metabolic age on Essential is an in-house score from HbA1c, fasting glucose, triglycerides, HDL, non-HDL cholesterol, ALT, eGFR, waist-to-height ratio and systolic blood pressure. It is not a published or validated model, so it is read for change between visits rather than as a single verdict.

Only with a reason and your agreement. The programmes cover 40 or 55 biomarkers. If your history or examination points to one of eight possible additions, the physician explains why and gives the price (the laboratory’s price plus LKR 500, between LKR 4,500 and 12,900), and it is confirmed in writing before the draw. Three follow-on tests (free T4, folate and SHBG) are run only if a first result calls for them, at laboratory cost, and only with your prior written agreement. The additions, the follow-on tests and their prices are listed on the biomarkers page.

It covers the screenings that are due. The report lists the cancer screenings due for your age, sex and family history: bowel, cervical and breast, and for men aged 50 to 69 a conversation about PSA. A bowel screening stool test (LKR 5,000) and, after that conversation, a PSA test (LKR 8,000) can be added to the same draw; cervical and breast screening are referred to where they are done. Blood tumour markers such as CA-125, CEA or CA 19-9 are not used to screen people without symptoms; PSA is offered only after a conversation about what it can and cannot show.

Yes. Diaspora patients visiting Sri Lanka schedule the review during their trip. Contact at least two weeks before arrival so that the draw and the report fit inside the visit.